The estimated Net Worth of Kevin Robert Lind is at least $796 Mille dollars as of 13 February 2020. Kevin Lind owns over 4,500 units of Arena Pharmaceuticals Inc stock worth over $795,620 and over the last 8 years Kevin sold ARNA stock worth over $0.
Kevin has made over 2 trades of the Arena Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Kevin exercised 4,500 units of ARNA stock worth $119,700 on 13 February 2020.
The largest trade Kevin's ever made was exercising 6,300 units of Arena Pharmaceuticals Inc stock on 14 October 2019 worth over $629,937. On average, Kevin trades about 1,543 units every 17 days since 2016. As of 13 February 2020 Kevin still owns at least 7,957 units of Arena Pharmaceuticals Inc stock.
You can see the complete history of Kevin Lind stock trades at the bottom of the page.
Kevin's mailing address filed with the SEC is C/O ARENA PHARMACEUTICALS, INC., 6154 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121.
Over the last 21 years, insiders at Arena Pharmaceuticals Inc have traded over $9,243,184 worth of Arena Pharmaceuticals Inc stock and bought 78,040 units worth $252,505 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Manmeet Singh Soni e Garry Arthur Neil. On average, Arena Pharmaceuticals Inc executives and independent directors trade stock every 39 days with the average trade being worth of $3,133,387. The most recent stock trade was executed by Amit Munshi on 16 August 2021, trading 1,000 units of ARNA stock currently worth $48,190.
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Arena Pharmaceuticals Inc executives and other stock owners filed with the SEC include: